Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ClosetInvestor's Profile
Displaying 201-250 of 1914 result(s).
CYDY CytoDyn Inc
02/14/2021 3:21:45 PM
“The way I see it, the turnaround
CYDY CytoDyn Inc
02/13/2021 11:04:44 PM
“I’ll take the word over someon (3)
CYDY CytoDyn Inc
02/13/2021 10:07:36 PM
“Once again I would have to take (6)
CYDY CytoDyn Inc
02/13/2021 9:26:00 PM
Here’s the post I was referring t (2)
CYDY CytoDyn Inc
02/13/2021 9:19:23 PM
“Your source was probably just mi (2)
CYDY CytoDyn Inc
02/13/2021 9:16:07 PM
Thought for the board that I shared (7)
CYDY CytoDyn Inc
02/13/2021 8:40:49 PM
“forgive me if I missed this long (3)
CYDY CytoDyn Inc
02/13/2021 10:52:56 AM
“Has anyone rebutted Midas letter (8)
CYDY CytoDyn Inc
02/10/2021 9:08:36 PM
We know it’s inaccurate because C (2)
CYDY CytoDyn Inc
02/10/2021 8:03:54 PM
“He dropped the name of Dr. Balan (3)
CYDY CytoDyn Inc
02/10/2021 11:18:32 AM
“If CD12 is an adaptive trial, ca (10)
CYDY CytoDyn Inc
02/08/2021 6:53:46 PM
“I'm trying to figure out why I d (3)
CYDY CytoDyn Inc
02/06/2021 11:49:42 AM
Not even close to being a similar c (3)
CYDY CytoDyn Inc
02/06/2021 8:49:09 AM
“But I don't believe for one minu (8)
CYDY CytoDyn Inc
02/06/2021 12:05:13 AM
“Maybe Pourhassan, Kelly, and the (6)
CYDY CytoDyn Inc
02/03/2021 6:49:13 PM
You’re so uncultured. (1)
CYDY CytoDyn Inc
02/01/2021 12:08:37 AM
Yes, leronlimab may be able to help (4)
CYDY CytoDyn Inc
01/28/2021 7:08:08 PM
Here’s the settlement that CYDY (2)
CYDY CytoDyn Inc
01/27/2021 3:12:09 PM
Soft basher. Go over to LieHub. (4)
CYDY CytoDyn Inc
01/27/2021 1:57:48 PM
“Andrew is out of business.” I
CYDY CytoDyn Inc
01/27/2021 9:44:01 AM
“Does anyone know if the data was
CYDY CytoDyn Inc
01/25/2021 11:41:28 AM
https://www.pmwcintl.com/covid/ Le (5)
CYDY CytoDyn Inc
01/25/2021 9:34:43 AM
“You can't apply a AVG PE to the (6)
CYDY CytoDyn Inc
01/21/2021 11:21:55 PM
“Hmmm. Probably imply that Cytody (5)
CYDY CytoDyn Inc
01/21/2021 9:16:08 PM
“You are kidding, right? The list (1)
CYDY CytoDyn Inc
01/21/2021 8:45:38 PM
“Is this something to worry about (2)
CYDY CytoDyn Inc
01/19/2021 1:28:07 PM
“but new buyers will certainly sh (1)
CYDY CytoDyn Inc
01/19/2021 8:44:44 AM
Easy answer: CYDY filed for EUA for (2)
CYDY CytoDyn Inc
01/18/2021 7:41:10 PM
Let’s get this “trial complete (5)
CYDY CytoDyn Inc
01/18/2021 3:05:27 PM
“You claim to be invested but the (7)
CYDY CytoDyn Inc
01/18/2021 2:19:02 PM
“In all seriousness, CI is probab (2)
CYDY CytoDyn Inc
01/17/2021 9:10:01 PM
“I believe Dr Patterson's paper r
CYDY CytoDyn Inc
01/17/2021 8:41:21 PM
“Was this not recognized at the M (2)
CYDY CytoDyn Inc
01/17/2021 7:40:18 PM
“How confident are you in the 32. (3)
CYDY CytoDyn Inc
01/17/2021 5:41:29 PM
“700mg IV Leronlimab, administere (3)
CYDY CytoDyn Inc
01/17/2021 5:21:40 PM
“IMO, ideally, the extreme critic (2)
CYDY CytoDyn Inc
01/17/2021 4:16:28 PM
“Why wouldn't Leronlimab be an *a (4)
CYDY CytoDyn Inc
01/17/2021 10:46:07 AM
“But that just cannot be. CI clai (6)
CYDY CytoDyn Inc
01/16/2021 10:24:50 PM
“I can tell you haven’t had it. (4)
CYDY CytoDyn Inc
01/16/2021 7:32:48 PM
“13 Israelis suffer FACIAL PARALY (1)
CYDY CytoDyn Inc
01/16/2021 8:56:20 AM
This assay is for MABs that target (3)
CYDY CytoDyn Inc
01/15/2021 4:20:47 PM
“Have to assume you're giggling a (2)
CYDY CytoDyn Inc
01/15/2021 1:42:50 PM
Primary Endpoint of the M2M trial:
CYDY CytoDyn Inc
01/15/2021 12:53:09 PM
“What takes longer to analyze? NE (1)
CYDY CytoDyn Inc
01/15/2021 12:28:56 PM
“Back to my thought. The endpoint (1)
CYDY CytoDyn Inc
01/15/2021 11:13:22 AM
“The next 5 days unfortunately ha (3)
CYDY CytoDyn Inc
01/14/2021 3:08:40 PM
“They would only do so if there w (1)
CYDY CytoDyn Inc
01/14/2021 2:02:41 PM
“Since a trial halt at 75% would (4)
CYDY CytoDyn Inc
01/14/2021 1:53:17 PM
The Phillippines released official
CYDY CytoDyn Inc
01/14/2021 10:43:26 AM
“Wasn't CYDY/their agent out ther (2)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Xlence's Role as Diamond Sponsor at Trading Show 2025
  • Xlence Takes Center Stage at The Trading Show 2025 in Casablanca
  • Investors Encouraged to Join Class Action Against Vestis Corp
  • Gregg Alexander's Iconic Comeback with BMI Pop Award Recognition
  • JBS USA Food Company's Successful Tender Offer for Notes
  • Understanding Recent Allegations Against Rocket Pharmaceuticals Inc
  • Understanding Class Action Options for Tempus AI Inc (TEM) Investors
  • Understanding the Class Action Lawsuit Against PepGen Inc. PEPG
  • Legal Actions for KnowBe4 Shareholders: Keep Informed
  • Unlock Daily Earnings with SunnyMining's New Cloud Plan
  • Snowcap Compute Secures $23M to Transform AI and Quantum Tech
  • Exciting Midwest Flower Expo to Foster Cannabis Network Growth
  • Apple's 'F1: The Movie' Surges in Previews, M3GAN 2.0 Slows
  • Analyzing Cavco Industries (CVCO): A Deep Dive into Valuation
  • Weather Challenges and Their Impact on Primo Brands' Sales
  • Lysander Funds Expands with Exciting New Canadian Equity Offerings
  • Understanding Dell Technologies' Stock Performance Analysis
  • Analyzing SoFi Technologies: Market Trends and Insights
  • Cipher Mining Sees Increased Bullish Options Activity
  • Recent Trends in MongoDB's Options Trading Explained
  • President Trump Engages with LindellTV Reporter in Briefing Room
  • Scotia Global Asset Management's Strategic Fund Adjustments
  • Cannabis Stock Insights: Market Trends and Key Movers
  • Gemini Enhances Market with Dinari's Tokenized Equities Launch
  • Analyzing State Street's Stock Performance and P/E Ratio
  • Gemini Expands its Offerings with Tokenized U.S. Equities
  • Palantir's Future Brightens with New Opportunities and Valuation
  • Understanding the P/E Ratio of Automatic Data Processing Inc.
  • Carr Workplaces Empowers Professionals with New Club App
  • Artis Real Estate Trust Shares Insights in 2024 ESG Report
  • PROREIT Expands Industrial Portfolio with Strategic Acquisition
  • Navigating Home Equity Agreements in Today's Real Estate Market
  • Empowering Renters: New Tools to Find Healthier Neighborhoods
  • Belveron Partners Achieves Milestone at AIDS/LifeCycle Event
  • Simon Property Group Expands Retail Portfolio with New Acquisition
  • Simon Property Group Expands Footprint with New Acquisition
  • BFC Partners Secures Major Funding for Affordable Housing Project
  • Homeowner's Brilliant Tiny Home Turned Rental Strategy Profits
  • New Trends in Home Sales: What Builders Are Facing in 2025
  • Exciting New Luxury Development Kicks Off in Downtown Area
  • Exciting Developments Ahead for Plamondon Hospitality Partners
  • H&R Real Estate Investment Trust Shares Voting Outcome Insights
  • Completion of Property Sale and Special Distribution Announcement
  • Understanding the Shift in Short Interest for PENN Entertainment
  • Transforming $1000 into $4025: The ICE Investment Story
  • Explore the Growth of Interactive Brokers Group Over 5 Years
  • Incredible Growth: How TSM Investment Has Thrived in 15 Years
  • How EMCOR Group Stock Has Thrived Over the Past Decade
  • How a $1000 Investment in US Foods Has Grown Over 5 Years
  • Investing in CBRE Group: How $1000 Turned into $3150
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site